Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

(Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short of expectations on Thursday, marking the fifth ...

Kenvue reported third-quarter sales slightly below Wall Street expectations on Thursday, hurt by weak sales of its skin ...

Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its skin health ...

Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

Kenvue owns a strong portfolio of household brands like Tylenol, Benadryl and Band-Aid. Read why I continue to rate KVUE ...

Kenvue, Inc. ( (KVUE)) has released its Q3 earnings. Here is a breakdown of the information Kenvue, Inc. presented to its investors. Kenvue, Inc., the world’s largest pure-play consumer health company ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...

The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...

Jefferies has recently initiated Kenvue Inc (KVUE) stock to Buy rating, as announced on September 24, 2024, according to Finviz. Earlier, on September 24, 2024, RBC Capital Mkts had reduced the stock ...

Negative blocking isn’t the healthiest – or the most efficient – way to approach brand safety, says Kenvue's Mark Proulx.